Literature DB >> 28232583

Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.

Yoshitaka Zaimoku1,2, Hiroyuki Takamatsu1, Kazuyoshi Hosomichi3, Tatsuhiko Ozawa4, Noriharu Nakagawa1, Tatsuya Imi1, Hiroyuki Maruyama1, Takamasa Katagiri5, Hiroyuki Kishi4, Atsushi Tajima3, Atsushi Muraguchi4, Koichi Kashiwase6, Shinji Nakao1.   

Abstract

To identify HLA alleles closely involved in the autoantigen presentation in acquired aplastic anemia (AA), we studied the HLA allelic loss frequencies of 312 AA patients, including 43 patients with loss of heterozygosity of 6p chromosome (6pLOH). An analysis of the HLA alleles contained in the lost haplotype revealed HLA-B*40:02 to be the most frequently lost allele. When we examined 28 AA (12 6pLOH[+] and 16 6pLOH[-]) patients with HLA-B*40:02 for the presence of leukocytes lacking HLA-B4002 (B4002-) using a new monoclonal antibody specific to this allele, B4002- granulocytes were detected not only in all 6pLOH(+) patients but also in 9 (56%) of the 16 6pLOH(-) patients. Furthermore, 10 (83%) of the 12 6pLOH(+) patients possessed 1.0% to 78% B4002- granulocytes that retained the HLA-A allele on the same haplotype (B4002-A+), suggesting the frequent coexistence of granulocytes that underwent mutations restricted to HLA-B*40:02 with 6pLOH(+) (B4002-A-) granulocytes. Deep sequencing of the HLA-B*40:02 of sorted B4002-A+ granulocytes revealed various somatic mutations, such as frameshift, nonsense, and splice site mutations, in all 15 patients studied. Surprisingly, missense mutations in the α-3 domain of HLA-B*40:02 that are not involved in the antigen presentation were detected exclusively in the B4002+ granulocytes of 3 patients possessing B4002- granulocytes. The markedly high prevalence of leukocytes lacking HLA-B4002 as a result of either 6pLOH or structural gene mutations, or both, suggests that antigen presentation by hematopoietic stem/progenitor cells to cytotoxic T cells via the HLA-B allele plays a critical role in the pathogenesis of AA.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28232583     DOI: 10.1182/blood-2016-11-752378

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

Review 1.  A brief, but comprehensive, guide to clonal evolution in aplastic anemia.

Authors:  Daria V Babushok
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Escape hematopoiesis by HLA-B5401-lacking hematopoietic stem progenitor cells in men with acquired aplastic anemia.

Authors:  Mahmoud I Elbadry; Hiroki Mizumaki; Kohei Hosokawa; J Luis Espinoza; Noriharu Nakagawa; Kazuhisa Chonabayashi; Yoshinori Yoshida; Takamasa Katagiri; Kazuyoshi Hosomichi; Yoshitaka Zaimoku; Tatsuya Imi; Mai Anh Thi Nguyen; Youichi Fujii; Atsushi Tajima; Seishi Ogawa; Katsuto Takenaka; Koichi Akashi; Shinji Nakao
Journal:  Haematologica       Date:  2019-03-19       Impact factor: 9.941

3.  Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.

Authors:  Sharon A Savage; Mathias Viard; Colm O'hUigin; Weiyin Zhou; Meredith Yeager; Shengchao Alfred Li; Tao Wang; Veron Ramsuran; Nicolas Vince; Aurelie Vogt; Belynda Hicks; Laurie Burdett; Charles Chung; Michael Dean; Kelvin C de Andrade; Neal D Freedman; Sonja I Berndt; Nathaniel Rothman; Qing Lan; James R Cerhan; Susan L Slager; Yawei Zhang; Lauren R Teras; Michael Haagenson; Stephen J Chanock; Stephen R Spellman; Youjin Wang; Amanda Willis; Medhat Askar; Stephanie J Lee; Mary Carrington; Shahinaz M Gadalla
Journal:  Am J Hum Genet       Date:  2020-01-30       Impact factor: 11.025

Review 4.  Diagnosis and Treatment of Aplastic Anemia.

Authors:  Scott A Peslak; Timothy Olson; Daria V Babushok
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

Review 5.  Clinical implications of somatic mutations in aplastic anemia and myelodysplastic syndrome in genomic age.

Authors:  Jaroslaw P Maciejewski; Suresh K Balasubramanian
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Clonality in context: hematopoietic clones in their marrow environment.

Authors:  James N Cooper; Neal S Young
Journal:  Blood       Date:  2017-10-18       Impact factor: 22.113

7.  Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Authors:  Lova Sun; Daria V Babushok
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

8.  Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.

Authors:  Tatsuya Imi; Takamasa Katagiri; Kazuyoshi Hosomichi; Yoshitaka Zaimoku; Viet Hoang Nguyen; Noriharu Nakagawa; Atsushi Tajima; Tetsuichi Yoshizato; Seishi Ogawa; Shinji Nakao
Journal:  Blood Adv       Date:  2018-05-08

9.  Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.

Authors:  Daria V Babushok; Jamie L Duke; Hongbo M Xie; Natasha Stanley; Jamie Atienza; Nieves Perdigones; Peter Nicholas; Deborah Ferriola; Yimei Li; Hugh Huang; Wenda Ye; Jennifer J D Morrissette; Jane Kearns; David L Porter; Gregory M Podsakoff; Laurence C Eisenlohr; Jaclyn A Biegel; Stella T Chou; Dimitrios S Monos; Monica Bessler; Timothy S Olson
Journal:  Blood Adv       Date:  2017-10-10

10.  Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.

Authors:  J Luis Espinoza; Mahmoud I Elbadry; Kazuhisa Chonabayashi; Yoshinori Yoshida; Takamasa Katagiri; Kenichi Harada; Noriharu Nakagawa; Yoshitaka Zaimoku; Tatsuya Imi; Hiroyuki Takamatsu; Tatsuhiko Ozawa; Hiroyuki Maruyama; Hassan A Hassanein; Amal Khalifa A Noreldin; Katsuto Takenaka; Koichi Akashi; Hiroshi Hamana; Hiroyuki Kishi; Yoshiki Akatsuka; Shinji Nakao
Journal:  Blood Adv       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.